Vimovo is a prescription medicine used for certain people who need naproxen for arthritis symptoms and also need help lowering the risk of naproxen-related stomach ulcers. It combines naproxen, a nonsteroidal anti-inflammatory drug, or NSAID, with esomeprazole magnesium, a proton pump inhibitor, or PPI.
Vimovo may be prescribed for signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis in adolescents who meet age and weight criteria. It is not an over-the-counter pain reliever, and it is not usually recommended as the first medicine for sudden acute pain because the naproxen component is absorbed more slowly than some other naproxen products.
Like all NSAID-containing medicines, Vimovo has important safety risks. This guide explains how Vimovo works, what it is used for, common and serious side effects, dosage information, interactions, and when to contact a healthcare provider.
Medical note: This article is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always ask your healthcare provider or pharmacist before starting, stopping, or changing any medication.
How does Vimovo work?
Vimovo is a delayed-release prescription tablet that contains two medicines:
|
Ingredient |
What it does |
| Naproxen | An NSAID that helps reduce pain, inflammation, swelling, and stiffness |
| Esomeprazole magnesium | A PPI that reduces stomach acid and helps lower the risk of naproxen-associated gastric ulcers |
Vimovo works through two ingredients. Naproxen helps reduce arthritis pain and inflammation, while esomeprazole reduces stomach acid to help lower the risk of naproxen-associated stomach ulcers.
How naproxen helps with arthritis pain
Naproxen is a nonsteroidal anti-inflammatory drug (NSAID). NSAIDs reduce the body’s production of substances involved in pain, inflammation, and fever. For arthritis, naproxen may help with symptoms such as:
-
- joint pain
- swelling
- stiffness
- tenderness
- reduced comfort with movement
Naproxen may help relieve symptoms, but it does not cure arthritis. It also does not reverse joint damage or replace disease-modifying treatment for autoimmune arthritis conditions such as rheumatoid arthritis.
How esomeprazole helps protect the stomach
Esomeprazole is a proton pump inhibitor (PPI). PPIs reduce the amount of acid made in the stomach. In Vimovo, esomeprazole is included to help lower the risk of gastric ulcers caused by naproxen.
This stomach-acid reduction can be useful for some people who need naproxen, but it does not make Vimovo risk-free. Serious gastrointestinal bleeding, ulceration, and perforation can still occur with NSAID therapy and may happen without warning symptoms.
Vimovo is also formulated so that the esomeprazole component is released before the naproxen component. This is part of the reason Vimovo is not recommended for the initial treatment of acute pain. The naproxen in Vimovo is absorbed more slowly than naproxen from some other naproxen-containing products.
For sudden pain, a healthcare provider may recommend a different approach.
What is Vimovo used for?
Vimovo is used to relieve signs and symptoms of certain arthritis conditions in people who also need to reduce the risk of developing naproxen-associated gastric ulcers.
Vimovo for osteoarthritis
Vimovo may be prescribed for adults with osteoarthritis, a common form of arthritis linked to joint wear, cartilage breakdown, and inflammation. Osteoarthritis often affects the knees, hips, hands, spine, and other joints.
For osteoarthritis, Vimovo may help reduce symptoms such as pain, stiffness, and inflammation. It does not rebuild cartilage or cure the condition. Treatment choices depend on a person’s age, symptom severity, stomach ulcer risk, heart risk, kidney function, other medications, and other health conditions.
Vimovo for rheumatoid arthritis
Vimovo may be used for signs and symptoms of rheumatoid arthritis in adults. Rheumatoid arthritis is an autoimmune condition that can cause joint pain, swelling, stiffness, and long-term joint damage. Vimovo may help relieve pain and inflammation, but it is not a disease-modifying antirheumatic drug. It does not treat the underlying immune process that drives rheumatoid arthritis.
Vimovo for ankylosing spondylitis
Vimovo may be prescribed for signs and symptoms of ankylosing spondylitis, an inflammatory arthritis condition that often affects the spine and sacroiliac joints. NSAIDs are commonly used in inflammatory back pain, but they are not appropriate for everyone. Your healthcare provider will consider cardiovascular risk, kidney function, GI bleeding risk, and other medications before prescribing Vimovo.
Vimovo for juvenile idiopathic arthritis
Vimovo may be used in adolescents with juvenile idiopathic arthritis who are at least 12 years old and weigh at least 38 kg, or about 84 pounds.
Juvenile idiopathic arthritis (JIA) is a type of arthritis that affects children younger than 16 years old. It causes joint inflammation and stiffness that lasts for at least 6 weeks. “Idiopathic” means the exact cause is unknown, but JIA is considered an autoimmune disease, meaning the immune system mistakenly attacks healthy tissues in the joints.
Children with JIA may experience:
-
- joint pain, swelling, or stiffness
- limping, especially in the morning
- warm or red joints
- fatigue or low energy
- fever or rash in some cases
- difficulty moving certain joints
Vimovo dosage guide
Vimovo is usually taken twice daily as prescribed.
|
Patient group |
Listed Vimovo dosage |
| Adults | 375 mg/20 mg or 500 mg/20 mg twice daily |
| Adolescents 12 years and older weighing more than 50 kg | 375 mg/20 mg or 500 mg/20 mg twice daily |
| Adolescents 12 years and older weighing 38 kg to less than 50 kg | 375 mg/20 mg twice daily |
Your prescriber may choose the lower or higher naproxen strength based on symptoms and safety considerations.
How to take Vimovo
Vimovo should be taken:
-
- At least 30 minutes before meals
- Swallowed whole with liquid
- Without splitting, chewing, crushing, or dissolving the tablet
Antacids may be used while taking Vimovo if needed, but you should ask your healthcare provider or pharmacist about the safest way to manage ongoing stomach symptoms.
If you miss a dose, take it as soon as you remember, unless it is close to your next scheduled dose. Do not take two doses at once to make up for a missed dose.
How long can you take Vimovo?
Vimovo should be used at the lowest effective naproxen dose for the shortest duration consistent with treatment goals. Controlled studies cited in the prescribing information do not extend beyond 6 months.
Risks of long-term naproxen use include:
Common side effects of Vimovo
Vimovo can cause side effects from either naproxen or esomeprazole. Some side effects are mild, while others can be serious.
Common or possible side effects may include:
-
- upset stomach
- nausea
- diarrhea
- constipation
- gas
- headache
- dizziness
- heartburn-like symptoms
- swelling or fluid retention
- increased blood pressure
Not every person will experience these effects. Some side effects may improve, while others may signal a need to change treatment.
Serious side effects and when to get medical help
Some Vimovo side effects need urgent medical attention.
Seek emergency medical help for chest pain, shortness of breath, weakness on one side of the body, slurred speech, vomiting blood, black or bloody stools, severe allergic reaction, severe skin rash, or sudden swelling of the face or throat.
Heart and stroke risks
Naproxen and other NSAIDs may increase the risk of serious cardiovascular events, including heart attack and stroke. These events may happen without warning and can be fatal.
Get emergency help if you have:
-
- chest pain
- shortness of breath
- sudden weakness
- trouble speaking
- sudden vision changes
- pain spreading to the arm, jaw, neck, or back
- sudden severe dizziness or fainting
People with heart disease or risk factors for heart disease should discuss NSAID risks with their healthcare provider before taking Vimovo.
Stomach bleeding and ulcer symptoms
NSAIDs can cause serious stomach and intestinal events, including bleeding, ulceration, and perforation. These events can happen at any time and may occur without warning symptoms. Older adults and people with a history of ulcers or GI bleeding may have a higher risk.
Call a healthcare provider right away or seek urgent care for:
-
- black or tarry stools
- bloody stools
- vomit that looks bloody or like coffee grounds
- severe stomach pain
- unexplained weakness
- fainting
- persistent nausea or loss of appetite
Kidney, liver, and blood pressure concerns
Vimovo can affect kidney function, fluid balance, and blood pressure. People with kidney disease, heart failure, liver disease, or high blood pressure may need extra caution.
Contact a healthcare provider for:
-
- less urination than usual
- swelling in the feet, ankles, legs, or hands
- unexplained weight gain
- new or worsening high blood pressure
- unusual fatigue
- yellowing of the skin or eyes
- dark urine
Low magnesium and PPI-related concerns
Long-term PPI use has been associated with low magnesium in some people. Symptoms can include muscle spasms, irregular heartbeat, dizziness, seizures, or weakness. Esomeprazole may also affect the absorption or levels of certain medicines.
People who take Vimovo long term should ask whether they need monitoring, especially if they also take diuretics, digoxin, or other medicines that can affect magnesium levels.
Vimovo warnings and precautions
Vimovo contains naproxen, so it carries NSAID warnings. It also contains esomeprazole, which has its own precautions.
Cardiovascular and gastrointestinal warnings
NSAIDs may increase the risk of serious cardiovascular thrombotic events, including heart attack and stroke. These can be fatal. NSAIDs also increase the risk of serious GI events, including bleeding, ulceration, and perforation of the stomach or intestines. These can also be fatal.
Vimovo is contraindicated in the setting of coronary artery bypass graft surgery.
Pregnancy warning
People who are pregnant, planning pregnancy, or breastfeeding should talk with a healthcare provider before using Vimovo. NSAIDs may cause harm during pregnancy, especially later in pregnancy. A healthcare provider can explain the risks, timing concerns, and possible alternatives based on the person’s situation.
Older adults
Older adults may be more likely to have serious NSAID side effects, including stomach bleeding, kidney problems, blood pressure changes, and medication interactions. They may also be more likely to take blood thinners, aspirin, corticosteroids, or other medicines that increase risk.
Older adults should have a medication review before taking Vimovo.
Kidney or liver disease
Vimovo is not recommended for people with moderate to severe kidney impairment or severe hepatic impairment. The prescribing information also notes that people with mild to moderate hepatic impairment may need dose-related consideration under clinician guidance.
People with kidney disease, liver disease, heart failure, or dehydration should not assume Vimovo is safe without medical review.
Asthma, allergies, and NSAID sensitivity
Some people have serious allergic reactions to aspirin or other NSAIDs. Vimovo should generally be avoided in people with a history of allergic-type reactions after taking aspirin, naproxen, ibuprofen, or other NSAIDs unless a healthcare provider specifically determines otherwise.
Warning signs can include:
-
- wheezing
- shortness of breath
- hives
- facial swelling
- throat tightness
- severe rash
Vimovo drug interactions
Vimovo can interact with prescription medicines, over-the-counter medicines, supplements, and herbal products. Patients should give their healthcare provider and pharmacist a complete medication list before starting Vimovo.
Medications that may interact with Vimovo
|
Medication type |
Why it matters |
| Blood thinners such as warfarin | May increase bleeding risk |
| Aspirin | May increase bleeding risk and complicate NSAID therapy |
| Other NSAIDs, such as ibuprofen or naproxen | May increase side effects and overdose risk |
| Corticosteroids | May increase GI bleeding risk |
| SSRIs and SNRIs | May increase bleeding risk |
| ACE inhibitors, ARBs, and diuretics | May affect kidney function and blood pressure |
| Lithium | NSAIDs may increase lithium levels |
| Methotrexate | May increase toxicity risk |
| St. John’s wort or rifampin | May reduce esomeprazole effect |
| Certain antiretrovirals | May affect drug levels or absorption |
| Iron supplements | Acid reduction may affect absorption in some cases |
This is not a complete interaction list. Vimovo’s prescribing information includes detailed interaction guidance, and patients should ask a pharmacist before combining it with any new medicine or supplement.
Can you take Vimovo with Tylenol?
Tylenol, or acetaminophen, is not an NSAID. However, that does not mean it is automatically safe for every person to combine with Vimovo. Ask a healthcare provider or pharmacist before taking acetaminophen with Vimovo, especially if you have liver disease, drink alcohol regularly, take multiple pain medicines, or use other products that contain acetaminophen.
Can you take Vimovo with ibuprofen or Aleve?
In general, you should not combine Vimovo with other NSAIDs unless your healthcare provider specifically tells you to. Vimovo already contains naproxen. Aleve also contains naproxen, and ibuprofen is another NSAID. Taking multiple NSAIDs can increase the risk of stomach bleeding, kidney problems, high blood pressure, and other serious side effects.
Alcohol and Vimovo
Alcohol can increase the risk of stomach bleeding with NSAIDs. People who drink alcohol regularly should discuss this with their healthcare provider before taking Vimovo. Heavy alcohol use may also complicate liver, stomach, and medication safety risks.
Vimovo vs naproxen and esomeprazole taken separately
Vimovo contains naproxen and esomeprazole in one delayed-release prescription tablet. Some people wonder whether taking separate naproxen and esomeprazole is the same thing.
But they’re not the same.
Vimovo has a specific delayed-release formulation. The esomeprazole component is intended to be released before the naproxen component. Separate products may not match the same timing, formulation, or dosing pattern.
Separate medicines may offer more dosing flexibility, but they also require clear instructions. A patient should not switch from Vimovo to separate naproxen and esomeprazole, or vice versa, without prescriber guidance.
Which option is better?
Neither option is automatically better for everyone.
The choice depends on:
-
- arthritis diagnosis
- pain and inflammation severity
- ulcer risk
- heart and stroke risk
- kidney function
- liver function
- age
- other medications
- insurance coverage
- cost
- ability to follow dosing instructions
A healthcare provider can help decide which option fits your risks and treatment goals.
Bottom line
Vimovo is a prescription medicine that combines naproxen for arthritis pain and inflammation with esomeprazole to help reduce the risk of naproxen-associated gastric ulcers. It may be prescribed for certain people with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, or juvenile idiopathic arthritis who need naproxen and also need stomach ulcer risk reduction.
Even though Vimovo includes a stomach acid reducer, it still carries serious NSAID risks. These can include heart attack, stroke, stomach bleeding, ulcers, kidney problems, high blood pressure, and drug interactions. It is not right for everyone, and it should not be combined with other NSAIDs unless a healthcare provider specifically recommends it.
Before taking Vimovo, talk with your healthcare provider or pharmacist about your arthritis symptoms, medical history, current medications, stomach ulcer risk, heart risk, kidney function, pregnancy status, and treatment goals. This discussion can help determine whether Vimovo is an appropriate option or whether another arthritis pain treatment may be a better fit.
Frequently Asked Questions
Related Articles
Sources
HIGHLIGHTS OF PRESCRIBING INFORMATION OF VIMOVO. https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/VIMOVO/vimovo_fpi_english.pdf
Naproxen (oral route). (2026, May 1). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/naproxen-oral-route/description/drg-20069820
DailyMed – VIMOVO- naproxen and esomeprazole magnesium tablet, delayed release. (n.d.). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9513589d-ef5d-4b8d-a90a-6adb6af2ae11
